# Brexpiprazole

## Rexulti 1mg

| TAH Drug Code      | [OREX](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OREX)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Schizophrenia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | Initial, 1 mg orally once daily on days 1 through 4; titrate to 2 mg orally once daily on days 5 through 7, then to target dosage of 4 mg orally once daily beginning on day 8, based on response and tolerability; Maximum 4 mg orally once daily; periodically reassess dosage and need for treatment.                                                                                                                                                                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Hypersensitivity to brexpiprazole or any component of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Common Endocrine metabolic: Hyperglycemia (9% to 10% ), Serum triglycerides raised (Short-term use, 5% to 13%; long-term use, 13% to 17% ), Weight increased (Short-term use, 2% to 11%; long-term use, 20% to 30% ) Neurologic: Akathisia ( 4% to 14% ), Extrapyramidal movements, Excluding akathisia (5% to 6% ), Headache (4% to 9% ) Serious Cardiovascular: Cerebrovascular accident, Orthostatic hypotension ( 0.1% to 0.4% ), Syncope (0.1% ), Transient ischemic attack Endocrine metabolic: Diabetic ketoacidosis Hematologic: Agranulocytosis Neurologic: Seizure Psychiatric: At risk for suicide Other: Neuroleptic malignant syndrome |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/brexpiprazole-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

